Loughborough, United Kingdom

Christopher Luckhurst



Average Co-Inventor Count = 4.9

ph-index = 2

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 2009-2011

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Christopher Luckhurst: Innovator in Chemokine Modulation

Introduction

Christopher Luckhurst is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that modulate chemokine activity. With a total of 4 patents to his name, Luckhurst's work is paving the way for advancements in therapeutic treatments.

Latest Patents

Luckhurst's latest patents include innovative compounds such as Piperidines as chemokine modulators (CCR). These compounds are designed to modulate chemokine activity, specifically targeting CCR3, which has potential applications in treating conditions like asthma. Another notable patent is for compounds of formula (I), which outlines a process for their preparation, pharmaceutical compositions containing them, and their therapeutic uses.

Career Highlights

Christopher Luckhurst is currently associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca focuses on the development of novel therapeutic agents that can significantly impact patient care and treatment outcomes.

Collaborations

Throughout his career, Luckhurst has collaborated with esteemed colleagues such as Mark Furber and Hitesh Jayantilal Sanganee. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical sector.

Conclusion

Christopher Luckhurst's contributions to chemokine modulation exemplify the importance of innovation in the pharmaceutical industry. His patents and ongoing work continue to hold promise for future therapeutic advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…